VerityRank
Back to Rankings
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Brand VerifiedChina

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a leading Chinese multinational pharmaceutical and health products conglomerate headquartered in Guangzhou, Guangdong Province. With total annual revenue of CNY 77.66 billion (~USD 10.8 billion) in 2025, it ranks as the largest enterprise in the global Traditional Chinese Medicine (TCM) and wellness sector. The group operates across t

ChinaEst. 199727,057CNY 77.66 billionListed - SSE (600332.SH), HKEX (0874.HK)Score 88

Core Business Areas

Chemical pharmaceutical preparations, Traditional Chinese Medicine, herbal extracts, medicinal beverages, health supplements, retail pharmacy chains

Industry Rankings

VerityRank Score

88/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Guangzhou, Guangdong

Founded

1997

Employees

27,057

Listing

Listed - SSE (600332.SH), HKEX (0874.HK)

Categories

Traditional Chinese Medicine & Health Products Brands

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , Guangzhou Baiyunshan Revenue - StockAnalysis, Annual Report 2025 Analysis - Minichart, Yunnan Baiyao 2025 Net Profit Analysis - BigGo Finance